about
Advanced glycation end products in foods and a practical guide to their reduction in the dietOxidative Stress in Diabetic Nephropathy with Early Chronic Kidney DiseaseMolecular Mechanisms Underlying Peritoneal EMT and FibrosisRedox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and PodocytesThe role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspectiveRole of Neuropilin-1 in Diabetic NephropathyRole of T cells in type 2 diabetic nephropathyAdvanced glycation end products and diabetic complicationsInhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transitionDangers within: DAMP responses to damage and cell death in kidney disease.Multivariate analysis of matrix-assisted laser desorption/ionization mass spectrometric data related to glycoxidation products of human globins in nephropathic patients.Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study.Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study.In vitro galactation of human serum albumin: analysis of the protein's galactation sites by mass spectrometry.Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.DJC Suppresses Advanced Glycation End Products-Induced JAK-STAT Signaling and ROS in Mesangial CellsRole of transcription factor acetylation in diabetic kidney disease.Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneysReactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy.-374 T/A RAGE polymorphism is associated with chronic kidney disease progression in subjects affected by nephrocardiovascular disease.Endogenous secretory receptor for advanced glycation end products and chronic kidney disease in the elderly population.Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathyImmunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic miceRole of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.Inhibitory actions of selected natural substances on formation of advanced glycation endproducts and advanced oxidation protein productsRelationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: the Baltimore Longitudinal Study of AgingEffects of olmesartan on arterial stiffness in rats with chronic renal failure.Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetesPeriodontal disease: the influence of metabolic syndromeUrinary albumin excretion and the renin-angiotensin system in cardiovascular risk management.Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food.Mechanism of increased clearance of glycated albumin by proximal tubule cells.Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling womenCarboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adultsBlockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats.Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women.Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults.Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
P2860
Q24602482-51689943-2A29-4D20-9C72-DA881A6CCAEDQ26741451-27380974-4F61-4059-B204-293837BADB80Q26768501-BDF604A3-6E40-4624-A26E-7D854D6EB280Q26778527-73EA00D2-2C81-48AC-83EE-EB318CA86229Q26795563-7D367D5B-4498-4A1A-8F95-73A3575E240AQ26799448-352F2610-D1D2-4303-AF47-96632A3DA27AQ26849691-26B09237-AB71-4F4D-AE92-1EDA92494E7FQ27687501-56CCC20D-D2D3-4696-82D1-047BB671E2B8Q29346955-EA3F677E-B190-458D-9BF7-F867FEDE69A7Q30380000-01BD1899-A611-444A-9D48-9B8B27D69AFEQ31107732-760B7088-2B6A-4727-9B13-D387A0D609EDQ33603990-A40DF456-DCBE-4EB9-AD0B-FC7790FDBC13Q33691339-26EEF85A-1ABE-476B-88DE-6B8C5B080098Q33723012-833F1584-6B83-46BD-9E29-C307186F553DQ33757191-5AA0EA71-23C8-4549-81E6-26CCEFA6B4D7Q33772238-0C9A3D17-D4B3-4EE3-8CBC-059F287C1C68Q33786872-B2CB6DAB-27F3-4172-8B64-B34E86AFB86AQ33789303-4E196EB4-FDCF-4CFF-BAB6-211DD6981D9EQ33901965-8CC5FDE5-1DD6-4B05-8EA3-A14E0DB17DF8Q33979367-F1D205D7-ED49-4670-88FF-CB4F8C93858BQ34672674-2E6E6F71-3CCC-4786-B27D-21105AA2EC51Q34724954-08CAF6FF-B441-48F2-8CFE-5BF229F17B74Q34981419-60B3B532-2332-4782-80BA-3CC54EC59A01Q35011158-31743770-CCA8-4A2C-8169-9EA20C6DBA18Q35766118-B2F367AE-B237-445B-9F91-8896A4E555D2Q35896615-FEC57C9A-FDF7-4D26-B842-C0DC9C9D8136Q36149136-C462E967-328F-4EA2-A753-54FEBA4E77CEQ36212513-C21BD258-191E-48DC-9387-3F42E41DBEA2Q36320297-D3A3A7B0-84EB-44C5-A51B-B9AC195ACBB8Q36334531-84B64CE2-405C-496F-807A-1A17349DD02DQ36403122-072BA195-66A7-43F8-B4B7-6BF3D2853855Q36675396-80688AD9-0956-4234-9D08-78E8D9DE4F7DQ36915810-6C077711-F71A-48DA-A61D-59126223012DQ36957107-3832CE24-1AD4-461B-96C4-C570359879ADQ37088388-17594616-A075-42A5-885F-75336F8B1EFAQ37088397-FB8B16DC-B841-4EF4-96BC-3035CC80A351Q37266352-BB0965B9-E63A-4F3F-B485-0BC9F499C9F3Q37300130-ED4B0077-6829-4A0A-A755-F2BBBD60A583Q37445850-48A071FF-C7BE-4D46-90B2-C63F3346E724Q37454060-097BF67F-5259-4A2B-A3EE-395EA9969E70
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Advanced glycation end products and the kidney.
@ast
Advanced glycation end products and the kidney.
@en
type
label
Advanced glycation end products and the kidney.
@ast
Advanced glycation end products and the kidney.
@en
prefLabel
Advanced glycation end products and the kidney.
@ast
Advanced glycation end products and the kidney.
@en
P2093
P1476
Advanced glycation end products and the kidney.
@en
P2093
Gunter Wolf
Günter Stein
Jürgen M Bohlender
Sybille Franke
P304
P356
10.1152/AJPRENAL.00398.2004
P577
2005-10-01T00:00:00Z